
Panama files lawsuits against owner of ports at centre of US-China struggle
The decision follows a failed attempt to sell the ports to a consortium headed by the US investment fund BlackRock and Swiss shipping firm MSC.
The two ports, at each end of the Panama Canal, were originally awarded to the Hong Kong-based firm CK Hutchison in 1997. They entered the geopolitical spotlight on 20 January when Trump used his inauguration speech to vow he would 'take back' the canal from supposed Chinese influence. The very same day, Anel Flores, the comptroller general, announced he would begin an audit of the ports' owner, Panama Ports Company, in which CK Hutchison holds a 90% stake.
In March, BlackRock, the world's biggest asset management company, announced it was working with MSC to acquire Panama Ports Company and 41 other ports in CK Hutchison's global portfolio.
The parties to the deal agreed a deadline of 27 July to finalize details of the acquisition.
But the sale of these strategic assets did not go down well in Beijing. On 28 March China's anti-trust regulator said it would review the deal 'to protect fair competition in the market and safeguard the public interest'.
Earlier this month the Wall Street Journal reported that the Chinese government had threatened to block the deal unless Cosco, a local shipping giant, was included as a veto-holding member of the takeover consortium.
On Wednesday, Flores said that Panama Ports' contract was 'unfair' and 'abusive'. He claimed that the company had not paid sufficient royalties to the government and that its 25-year extension, signed in 2023, was made without the necessary authorizations. One case lodged with the supreme court seeks to nullify the contract, the other seeks to declare it unconstitutional.
In response to media speculation that Cosco would be included in the deal he said: 'It doesn't seem correct that in other [parts of the world] there are people negotiating the future of assets that belong to us, the Panamanians.'
Panama's president, José Raúl Mulino, said on Thursday, that he supported Flores's decision – which he claimed had nothing to do with the ongoing struggle over the ports' ownership.
However, the timing of the announcement is convenient for the US-backed consortium. Should the court cases prove successful, the contracts for port operations would have to be re-tendered and, with Panama having exited China's Belt and Road Initiative in April, it would seem likely the successful bid will come from a US firm or an ally country.
Nullifying the PPC contract and re-tendering the operation of the ports would allow Panama to potentially redesign the contract terms to be more beneficial to the state. However, the country could also find itself exposed to litigation from CK Hutchison which could potentially argue it is tantamount to a politically motivated expropriation.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
a few seconds ago
- Daily Mail
Donald Trump hits out at Federal Reserve as US jobs fall
Donald Trump launched a fresh attack on the chair of the Federal Reserve after the US jobs market suffered a sharp slowdown over the summer. The world's largest economy added just 73,000 jobs in July – fewer than the 110,000 expected – reviving hopes of a September interest rate cut. And figures for May and June were lowered by 258,000 in an unusually large revision by the US Bureau of Labor Statistics (BLS). In retaliation, Trump last night said he would sack BLS head Erika McEntarfer. It came as US stocks tumbled after Trump slapped tariffs on trading partners. The Dow Jones Industrial Average fell 1 per cent yesterday afternoon, while the S&P 500 dropped 1.2 per cent. The tech-focused Nasdaq was down 1.7 per cent. European stocks were also rocked by Trump's trade war, with Germany's Dax losing 2.7 per cent and Paris's Cac index dropping 2.9 per cent. The UK got off lightly as the FTSE 100 fell 0.7 per cent, or 64.23 points, to 9068.58. Pharmaceutical firms were among the biggest fallers in London after Trump demanded lower prices. AstraZeneca fell 1.9 per cent and GSK dropped 1.5 per cent. The retreat came as revised figures showed the US economy added just 14,000 jobs in June, a figure revised from a previously reported 147,000. Payrolls for May were slashed by 125,000 to a gain of 19,000 jobs. The BLS described revisions as 'larger than normal'. Atakan Bakiskan, US economist at Berenberg, said: 'The July report provided ammunition for those expecting a Fed rate cut in September.' 'This data has led to a rapid recalibration of US interest rate expectations,' Kathleen Brooks, research director at XTB, said. On his social media platform Truth Social, Trump wrote: 'Too little, too late. Jerome 'Too Late' Powell is a disaster. DROP THE RATE! .. Tariffs are bringing billions of dollars into the USA!' The President has branded the central bank chair a 'stubborn moron', saying he 'must lower interest rates now'. 'If he continues to refuse, the board should assume control and do what everyone knows has to be done,' he added. Reports last month suggested Powell's future could be in doubt after Trump met congressional Republicans to discuss sacking him. But the President later insisted he would only fire the central bank boss if he were guilty of fraud.


The Sun
a few seconds ago
- The Sun
Donald Trump vows to unleash ‘every tool in our arsenal' in price row with British drug firms
DONALD Trump insists he will unleash 'every tool in our arsenal' if British drug companies don't cut their prices within 60 days. The US President waged war with a total of seventeen firms demanding 'binding commitments' to match the lower prices offered to developing countries. The move comes as the White House hit dozens of countries with a fresh slew of tariffs including punishing levies on neighbour Canada. Two UK drug firms, AstraZeneca and GSK, caught up in the pharma row saw their share price drop as Trump aims to lower prices for American citizens. The move could even have damaging consequences for the NHS whose leverage with suppliers due to its size could be reduced. Mr Trump has demanded the firms apply their 'most favoured nation' rates to Medicaid which is the health system for low-income Americans. He said: 'Make no mistake: a collaborative effort towards achieving global pricing parity would be the most effective path for companies, the government, and American patients. In a letter to the firms, he said: 'But if you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices. 'Americans are demanding lower drug prices, and they need them today.' Around £16 billion was wiped off shares in the sector across Europe as fears grow higher prices in the rest of the world will fund the US reductions. The move comes after Trump said back in May that he wanted drug prices in the US to be reduced by 80 per cent. Moment Trump 'throws shade' at Meghan and Harry during Starmer press conference But experts appeared wary that he has the authority to reduce prices and a previous effort in his first term failed in court. At the time, he said the tactics were 'subsidising socialism' abroad in paying for the same pills from the same factories, which led to spiralling prices at home. The warning came as Mr Trump signed an executive order applying a wave of tariffs to 68 countries and the European Union. Canada was hit with levies – up to 35 per cent from 25 per cent - due to its lack of co-operation in stopping flow of illegal drugs and fentanyl into America. Their PM Mark Carney said that his country was 'making historic investments in border security to arrest drag traffickers and end migrant smuggling'. Switzerland will also keep negotiating with the US after their tariff rate hit 39 per cent, which was far higher than they anticipated. 1


Reuters
a few seconds ago
- Reuters
TRADING DAY Now that's a reality check
ORLANDO, Florida, Aug 1 (Reuters) - - TRADING DAY Making sense of the forces driving global markets By Jamie McGeever, Markets Columnist I'd love to hear from you, so please reach out to me with comments at opens new tab. You can also follow me at @ReutersJamie and @ Well, well, well. In a week jam-packed with global tariff, earnings, data and policy fireworks, the most explosive was kept for last: July's U.S. employment report, which shattered the optimism - or complacency - building around the U.S. economy and stock market. Weak job growth, together with the latest wave of steep tariffs imposed by U.S. President Donald Trump, triggered a huge selloff in global stocks and the dollar on Friday, floored bond yields, and revived expectations of a Fed rate cut next month. Today's Key Market Moves Now that's a reality check Global markets were floored on Friday by a powerful one-two punch from the latest U.S. employment data and U.S. tariffs slapped on dozens of countries. It was a sobering reminder that the economic foundations supporting Wall Street's record highs this week may not be that strong. The weak jobs growth seemed to fly in the face of Fed Chair Jerome Powell's assessment on Wednesday that the labor market is strong, and vindicate the two dissenters, Governors Christopher Waller and Michelle Bowman. Although to be fair to Powell, he did stress that downside risks were growing. Yet average earnings and hours worked rose in July, and the unemployment rate only inched up to 4.2%. That's effectively still full employment. If the bar to cutting rates is tied to the unemployment rate, it is still a high one. Rates futures traders don't see it that way though. They now see a rate cut next month as a near-certainty, and are pricing in 60 basis points of easing by year-end. Investors were also sideswiped on Friday by U.S. President Donald Trump's latest wave of tariffs on 69 trading partners, ranging from 10% to 41%, that will start in a week's time. This will raise the U.S. effective tariff rate closer to 20%, nearly 10 times higher than the end of last year. Of course, bilateral trade deals could be struck and these levies may be lowered, but it is a reminder that the growth and inflation outlook is challenging at best. With equity prices and optimism around Big Tech at such lofty levels, the correction when it came was always likely to be big. If that wasn't enough for investors to digest, Trump announced late on Friday he is firing the commissioner of the Labor Department's Bureau of Labor Statistics following the latest jobs data, and Fed Governor Adriana Kugler said she is resigning effective August 8 and returning to academia. This paves the way for Trump to appoint someone more aligned with his low interest rate view as her replacement. So the new trading month kicks off with world markets on a shaky footing, and the economy too. Asia's factory activity is deteriorating as tariff uncertainty weighs, and U.S. manufacturing is still in a funk. European factory activity is moving closer to stabilization, but is still contracting. Services, tech and AI-related activity and indicators are shining brighter of course, but even there caution will be creeping into investors' minds. Earnings reports from Apple, Microsoft and Meta were well-received by the market, to put it mildly, but the Nasdaq still shed nearly 2% on the week. August is the main summer holiday month in Europe and North America, so liquidity will thin out. With the VIX index back above 20.0 for the first time since April, trading next week could be choppy. Chart of the Week If you want evidence that Trump's tariffs on the rest of the world are starting to push up U.S. goods inflation, look no further. According to Ernie Tedeschi at the Budget Lab at Yale, PCE durable goods prices in the first six months of the year rose 1.7%. Excluding the pandemic, that's the biggest six-month rise since 1987. Here are some of the best things I read this week: What could move markets on Monday? Opinions expressed are those of the author. They do not reflect the views of Reuters News, which, under the Trust Principles, opens new tab, is committed to integrity, independence, and freedom from bias. Trading Day is also sent by email every weekday morning. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here.